RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes

Genes Chromosomes and Cancer

Volumn 45, Issue 8, 2006, Pages 761-769

  Kao, Jessica ^a   Pollack, Jonathan R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ONCOPROTEIN; SMALL INTERFERING RNA;

AMPLICON; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GENETICS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN; CHROMOSOME 17Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DETERMINATION; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GRB7 GENE; HUMAN; HUMAN CELL; HUMAN GENOME; KNOCKOUT GENE; MICROARRAY ANALYSIS; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; STARD3 GENE; WESTERN BLOTTING;

BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; GRB7 ADAPTOR PROTEIN; HUMANS; MEMBRANE PROTEINS; MODELS, GENETIC; PHENOTYPE; RNA INTERFERENCE; TRANSFECTION;

EID: 33745686009     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20339     Document Type: Article

References (29)

1. Abramoff MD, Magelhaes PJ, Ram SJ. 2004. Image processing with ImageJ., Biophotonics Int 11:36-42.
2. Akiyama N, Sasaki H, Ishizuka T, Kishi T, Sakamoto H, Onda M, Hirai H, Yazaki Y, Sugimura T, Terada M. 1997. Isolation of a candidate gene, CAB1, for cholesterol transport to mitochondria from the c-ERBB-2 amplicon by a modified cDNA selection method. Cancer Res 57:3548-3553.
3. Amarzguioui M, Rossi JJ, Kim D. 2005. Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Lett 579:5974-5981.
4. Choudhury A, Charo J, Parapuram SK, Hunt RC, Hunt DM, Seliger B, Kiessling R. 2004. Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. Int J Cancer 108:71-77.
5. Cohen JJ. 1993. Apoptosis. Immunol Today 14:126-130.
6. Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C, Theillet C. 1997. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: Definition of phenotypic groups. Cancer Res 57:4360-4367.
7. Faltus T, Yuan J, Zimmer B, Kramer A, Loibl S, Kaufmann M, Strebhardt K. 2004. Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells. Neoplasia 6:786-795.
8. Flototto T, Djahansouzi S, Glaser M, Hanstein B, Niederacher D, Brumm C, Beckmann MW. 2001. Hormones and hormone antagonists: Mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm Metab Res 33:451-457.
9. Gisselsson D. 2003. Chromosome instability in cancer: How, when, and why? Adv Cancer Res 87:1-29.
10. Han DC, Shen TL, Guan JL. 2001. The Grb7 family proteins: Structure, interactions with other signaling molecules and potential cellular functions. Oncogene 20:6315-6321.
11. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP, Kallioniemi A. 2002. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62:6240-6245.
12. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635-637.
13. Kauraniemi P, Kuukasjarvi T, Sauter G, Kallioniemi A. 2003. Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer. Am J Pathol 163:1979-1984.
14. Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y. 1998. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies. Am J Pathol 152:1107-1123.
15. Lewis GD, Figari I, Fendly B, Wong WL, Carter P, Gorman C, Shepard HM. 1993. Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies. Cancer Immunol Immunother 37:255-263.
16. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
17. Moog-Lutz C, Tomasetto C, Regnier CH, Wendling C, Lutz Y, Muller D, Chenard MP, Basset P, Rio MC. 1997. MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int J Cancer 71:183-191.
18. Nonet GH, Stampfer MR, Chin K, Gray JW, Collins CC, Yaswen P. 2001. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res 61:1250-1254.
19. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, Brown PO. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Nat; Acad Sci USA 99:12963-12968.
20. Reese DM, Slamon DJ. 1997. HER-2/neu signal transduction in human breast and ovarian cancer. Stem Cells 15:1-8.
21. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK. 2005. SEER Cancer Statistics Review, 1975-2002. Bethesda, MD: National Cancer Institute.
22. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365-386.
23. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ. 1992. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355-361.
24. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L. 2001. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783-792.
25. Stein D, Wu J, Fuqua SA, Roonprapunt C, Yajnik V, D'Eustachio P, Moskow JJ, Buchberg AM, Osborne CK, Margolis B. 1994. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J 13:1331-1340.
26. Strauss JF, III, Kishida T, Christenson LK, Fujimoto T, Hiroi H. 2003. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol Cell Endocrinol 202:59-65.
27. Subramaniam DS, Isaacs C. 2005. Utilizing prognostic and predictive factors in breast cancer. Curr Treat Options Oncol 6:147-159.
28. Tuschl T, Borkhardt A. 2002. Small interfering RNAs: A revolutionary tool for the analysis of gene function and gene therapy. Mol Interv 2:158-167.
29. Watari H, Arakane F, Moog-Lutz C, Kallen CB, Tomasetto C, Gerton GL, Rio MC, Baker ME, Strauss JF, III. 1997. MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc Natl Acad Sci USA 94:8462-8467.